Annual Drug Patent Expirations for BLUDIGO
Bludigo is a drug marketed by Provepharm Sas and is included in one NDA. There is one patent protecting this drug.
This drug has two patent family members in two countries.
The generic ingredient in BLUDIGO is indigotindisulfonate sodium. Additional details are available on the indigotindisulfonate sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com